"Every day, I got on the scales and I still weighed exactly the same as before," Leith, 85, told U.K. paper 'The Times' ...

With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...

According to the latest results from Gallup’s survey, self-reported obesity has started to fall, declining by nearly 3 points to 37 percent in 2025. The self-repo ...

Exclusive: Australian doctors are being approached every day by teenagers and young adults – girls as well as boys – asking ...

The UK Government is funding a study which will involve 5,000 people from some of Scotland’s most deprived areas being given Wegovy injections.

Critics will understandably raise concerns about the cost to the NHS of giving out these injections. Wegovy is a weight loss ...

A major international study led by researchers at University College London has found that semaglutide, the active ingredient in Ozempic and Wegovy, may protect the heart even when users lose little ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Judging from the numbers I'm seeing, the black market for weight-loss jabs isn't small-scale. This is a massive operation.

Explore the fierce competition between Novo Nordisk and Pfizer as they vie for Metsera amidst a booming obesity drug market.

Explore how GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are impacting obesity rates in America, while also highlighting ...

Many need to stay slender to get acting roles or look good on stage, and medications such as Ozempic, Wegovy and Mounjaro ...